Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in the rat

European Journal of Pharmacology

Volumn 413, Issue 1, 2001, Pages 81-89

  Bienkowski, Przemyslaw ^a   Krzascik, Pawel ^b   Koros, Eliza ^a   Kostowski, Wojciech ^a,b   Scinska, Anna ^b   Danysz, Wojciech ^c  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Merz+Co ^*  (Germany)

Author keywords

(Rat); Ethanol self administration; Ethanol withdrawal; MRZ 2 579; NMDA receptor antagonist

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERAMEXANE;

ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SEIZURE; SLEEP TIME; WITHDRAWAL SYNDROME;

ALCOHOL DRINKING; ALCOHOL WITHDRAWAL SEIZURES; ANIMALS; CONDITIONING, OPERANT; CYCLOPENTANES; DIAZEPAM; EPILEPSY, REFLEX; ETHANOL; MALE; MEMANTINE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SELF ADMINISTRATION; SLEEP;

EID: 0035830652     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00743-9     Document Type: Article

References (58)

1. A and NMDA receptor antagonists on ethanol-induced behavioral sleep in rats
2. Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists
3. Discrimination of ethanol in rats: Effects of nicotine, diazepam, CGP 40116, and 1-(m-chlorophenyl)-biguanide
4. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol
5. Interactions of ethanol with nicotine, dizocilpine, CGP 40116, and 1-(m-chlorophenyl)-biguanide in rats
6. B sites) in the discriminative stimulus effects of ethanol in the rat
7. Ethanol-reinforced behaviour in the rat: Effects of naltrexone
8. Effects of N-methyl-D-aspartate receptor antagonists on reinforced and non-reinforced responding for ethanol in rats
9. Ethanol tolerance and synaptic plasticity
10. Quantitative trait locus analyses of sleep-times induced by sedative-hypnotics in LS×SS recombinant inbred strains of mice
11. High sensitivity to γ-hydroxybutyric acid in ethanol-preferring sP rats
12. Possible abuse potential of the NMDA receptor antagonist MK-801
13. The involvement of NMDA receptors in acute and chronic effects of ethanol
14. NMDA channel blockers: Memantine and amino-alkylcyclohexanes. In vivo characterisation
15. Dextromethorphan attenuates ethanol withdrawal syndrome in rats
16. Ethanol and neurotransmitter interactions-from molecular to integrative effects
17. Effects of NMDA antagonists on ethanol-withdrawal induced "anxiety" in the elevated plus maze
18. Ethanol withdrawal seizures and the NMDA receptor complex
19. Ethanol-like discriminative stimulus effects of noncompetitive N-methyl-D-aspartate antagonists
20. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal
21. Brain distribution of an uncompetitive NMDA receptor antagonist; comparison to its in vitro potency in electrophysiological studies
22. Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration
23. Glutamate receptors in alcohol withdrawal-induced neurotoxicity
24. Attenuation of glutamate-induced neurotoxicity in chronically ethanol-exposed cerebellar granule cells by NMDA receptor antagonists and ganglioside GM1
25. Effect of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats
26. Evidence for alcohol anti-craving properties of memantine
27. Novel uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure
28. Ethanol and N-methyl-D-aspartate receptor complex interactions: A detailed drug discrimination study in the rat
29. Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats
30. Role of brain norepinephrine in audiogenic seizures in rats
31. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy
32. Saccharin drinking rather than open field behavior predicts initial ethanol acceptance in Wistar rats
33. Discriminative stimulus effects of ethanol: Neuropharmacological characterization
34. 3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats
35. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures
36. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics
37. Potentiation of the ambulation increasing effect induced by combined administration of MK-801 with ethanol in mice
38. Cerestat and other NMDA antagonists in ischemic stroke
39. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures
40. Alcohols and neurotransmitter gated ion channels
41. Study of a new schizophrenomimetic drug, Sernyl
42. Induction of physical dependence upon ethanol and the associated behavioral changes in rats
43. Mapping rat brain structures activated during ethanol withdrawal: Role of glutamate and NMDA receptors
44. MK-801 potently inhibits alcohol withdrawal seizures in rats
45. Glutamate in CNS disorders as a target for drug development: An update
46. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: In vitro and in vivo characterization
47. Ethanol-reinforced behavior in the rat: Effects of uncompetitive NMDA receptor antagonist, memantine
48. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists
49. Seizures during ethanol withdrawal are blocked by focal microinjection of excitant amino acid antagonists into the inferior colliculus and pontine reticular formation
50. Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines
51. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum
52. Initiation of ethanol reinforcement using a sucrose-substitution procedure in food-and water-sated rats
53. Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice
54. Effects of γ-aminobutyric acid agonists and N-methyl-D-aspartate antagonists on a multiple schedule of ethanol and saccharin self-administration
55. New treatment options for substance abuse from a public health viewpoint
56. The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety
57. Behavioral sensitivity and ethanol potentiation of the N-methyl-D-aspartate receptor antagonist MK-801 in a rat line selected for high ethanol sensitivity
58. NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures